Ahmet Peker1, Mine Hayriye Sorgun2, Canan Togay Isikay2, Ethem Murat Arsava3, Mehmet Akif Topcuoglu3, Anil Arat4. 1. Department of Radiology, School of Medicine, Hacettepe University, Sıhhiye, 06100, Ankara, Turkey. 2. Department of Neurology, School of Medicine, Ankara University, Ankara, Turkey. 3. Department of Neurology, School of Medicine, Hacettepe University, Ankara, Turkey. 4. Department of Radiology, School of Medicine, Hacettepe University, Sıhhiye, 06100, Ankara, Turkey. anilarat@hotmail.com.
Abstract
PURPOSE: Contralateral carotid occlusion (CCO) increases the risk of carotid endarterectomy (CEA). We determined the outcome of carotid angioplasty and stenting (CAS), an alternative to CEA, in the setting of CCO through an independent analysis of imaging and clinical outcome. MATERIALS AND METHODS: Medical records of 26 consecutive patients with CCO who underwent CAS by a single operator using the same procedural protocol (with distal protection and closed-cell stents) were retrospectively evaluated. National Institutes of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) scores before and after CAS, periprocedural complications, and the restenosis rate were analyzed by independent stroke neurologists who were not involved in the care of the patients. RESULTS: The median mRS score for the 26 patients was 1 (range 0-5) before and after CAS. All of the patients underwent clinical and imaging follow-up (mean 19.5 ± 14.3 and 11.6 ± 11.2 months, respectively). Thirty-day mortality/permanent morbidity rates were 0 %. One patient had hyperperfusion syndrome and was managed medically without sequelae; however, he had stent occlusion after 30 days, resulting in a decline in his mRS from 4 (preprocedure) to 5. Otherwise, there was no decline in mRS during the post-discharge follow-up. CONCLUSION: According to an independent analysis of this single-operator series, CAS is safe and effective for the treatment of patients with CCO.
PURPOSE:Contralateral carotid occlusion (CCO) increases the risk of carotid endarterectomy (CEA). We determined the outcome of carotid angioplasty and stenting (CAS), an alternative to CEA, in the setting of CCO through an independent analysis of imaging and clinical outcome. MATERIALS AND METHODS: Medical records of 26 consecutive patients with CCO who underwent CAS by a single operator using the same procedural protocol (with distal protection and closed-cell stents) were retrospectively evaluated. National Institutes of Health Stroke Scale (NIHSS) and Modified Rankin Scale (mRS) scores before and after CAS, periprocedural complications, and the restenosis rate were analyzed by independent stroke neurologists who were not involved in the care of the patients. RESULTS: The median mRS score for the 26 patients was 1 (range 0-5) before and after CAS. All of the patients underwent clinical and imaging follow-up (mean 19.5 ± 14.3 and 11.6 ± 11.2 months, respectively). Thirty-day mortality/permanent morbidity rates were 0 %. One patient had hyperperfusion syndrome and was managed medically without sequelae; however, he had stent occlusion after 30 days, resulting in a decline in his mRS from 4 (preprocedure) to 5. Otherwise, there was no decline in mRS during the post-discharge follow-up. CONCLUSION: According to an independent analysis of this single-operator series, CAS is safe and effective for the treatment of patients with CCO.
Authors: Eric R Bates; Joseph D Babb; Donald E Casey; Christopher U Cates; Gary R Duckwiler; Ted E Feldman; William A Gray; Kenneth Ouriel; Eric D Peterson; Kenneth Rosenfield; John H Rundback; Robert D Safian; Michael A Sloan; Christopher J White Journal: J Am Coll Cardiol Date: 2007-01-02 Impact factor: 24.094
Authors: Alejandro González; Jose Ramón González-Marcos; Eva Martínez; Fernando Boza; Aurelio Cayuela; Antonio Mayol; Alberto Gil-Peralta Journal: Cerebrovasc Dis Date: 2005-12-02 Impact factor: 2.762
Authors: Ciaran J Powers; Joshua A Hirsch; M Shazam Hussain; Athos T Patsalides; Kristine A Blackham; Sandra Narayanan; Seon-Kyu Lee; Justin F Fraser; Ketan R Bulsara; Charles J Prestigiacomo; Chirag D Gandhi; Todd Abruzzo; Huy M Do; Philip M Meyers; Felipe C Albuquerque; Donald Frei; Michael E Kelly; G Lee Pride; Mahesh V Jayaraman Journal: J Neurointerv Surg Date: 2013-11-06 Impact factor: 5.836
Authors: Tiziano Tallarita; Alejandro A Rabinstein; Harry Cloft; David Kallmes; Gustavo S Oderich; Robert D Brown; Giuseppe Lanzino Journal: Stroke Date: 2011-05-12 Impact factor: 7.914
Authors: Mark L Keldahl; Michael S Park; Manuel Garcia-Toca; Chih-Hsiung E Wang; Melina R Kibbe; Heron E Rodriguez; Mark D Morasch; Mark K Eskandari Journal: Ann Vasc Surg Date: 2011-10-01 Impact factor: 1.466
Authors: Nestor Mercado; David J Cohen; John A Spertus; Paul S Chan; John House; Kevin Kennedy; Ralph G Brindis; Christopher J White; Kenneth A Rosenfield; Steven P Marso Journal: JACC Cardiovasc Interv Date: 2013-01 Impact factor: 11.195
Authors: A Mathur; G S Roubin; C R Gomez; S S Iyer; P M Wong; C Piamsomboon; S S Yadav; L S Dean; J J Vitek Journal: Am J Cardiol Date: 1998-06-01 Impact factor: 2.778